WallStreetZenWallStreetZen

NASDAQ: SKYE
Skye Bioscience Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for SKYE

Based on 2 analysts offering 12 month price targets for Skye Bioscience Inc.
Min Forecast
$20.00+53.85%
Avg Forecast
$22.50+73.08%
Max Forecast
$25.00+92.31%

Should I buy or sell SKYE stock?

Based on 2 analysts offering ratings for Skye Bioscience Inc.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their SKYE stock forecasts and price targets.

SKYE stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-12
lockedlocked$00.00+00.00%2024-03-14

1 of 1

SKYE revenue forecast

What is SKYE's revenue in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
$26.4M
Avg 2 year Forecast
$71.6M

SKYE vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ABCL$3.84$11.50+199.48%Strong Buy
ACAD$17.10$30.20+76.60%Buy
ABSI$4.78$9.25+93.51%Strong Buy
ABIO$3.43N/AN/A
ADIL$1.69N/AN/A
View Top Biotech Stocks

Skye Bioscience Stock Forecast FAQ

Is Skye Bioscience Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: SKYE) stock is to Strong Buy SKYE stock.

Out of 2 analysts, 1 (50%) are recommending SKYE as a Strong Buy, 1 (50%) are recommending SKYE as a Buy, 0 (0%) are recommending SKYE as a Hold, 0 (0%) are recommending SKYE as a Sell, and 0 (0%) are recommending SKYE as a Strong Sell.

If you're new to stock investing, here's how to buy Skye Bioscience stock.

What is SKYE's revenue growth forecast for 2029-2030?

(NASDAQ: SKYE) Skye Bioscience's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.

Skye Bioscience's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast SKYE's revenue for 2029 to be $740,299,487, with the lowest SKYE revenue forecast at $740,299,487, and the highest SKYE revenue forecast at $740,299,487.

In 2030, SKYE is forecast to generate $2,007,900,996 in revenue, with the lowest revenue forecast at $2,007,900,996 and the highest revenue forecast at $2,007,900,996.

What is SKYE's Price Target?

According to 2 Wall Street analysts that have issued a 1 year SKYE price target, the average SKYE price target is $22.50, with the highest SKYE stock price forecast at $25.00 and the lowest SKYE stock price forecast at $20.00.

On average, Wall Street analysts predict that Skye Bioscience's share price could reach $22.50 by Apr 12, 2025. The average Skye Bioscience stock price prediction forecasts a potential upside of 73.08% from the current SKYE share price of $13.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.